Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2010-12-22 (15 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ROISEL ([ND]), None
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE DE ROISEL : revenue, balance sheet and financial ratios
SELARL PHARMACIE DE ROISEL is a French company
founded 15 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ROISEL ([ND]),
this company of category PME
shows in 2024 a net income positive of 298 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE DE ROISEL (SIREN 529196685)
Indicator
2024
2023
2017
Revenue
N/C
N/C
N/C
Net income
298 390 €
383 983 €
341 337 €
EBITDA
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
Revenue and income statement
Im Jahr 2024 erzielt SELARL PHARMACIE DE ROISEL ein positives Nettoergebnis von 298 k€. Entwicklung 2017-2024: 341 k€ -> 298 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
298 390 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
Die Verschuldungsquote (= Finanzschulden / Eigenkapital x 100) beträgt 42%. Die Verschuldung bleibt unter Kontrolle. Die finanzielle Autonomie (= Eigenkapital / Bilanzsumme x 100) erreicht 68%. Diese hohe Autonomie bedeutet, dass das Unternehmen den Großteil seiner Vermögenswerte durch Eigenkapital finanziert.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
42.373%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
67.686%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE DE ROISEL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2023
2024
Debt ratio
56.924
33.939
42.373
Financial autonomy
60.018
70.921
67.686
Repayment capacity
None
None
None
Cash flow / Revenue
None%
None%
None%
Sector positioning
Verschuldungsgrad
42.372024
2017
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Gut+12 pts over 3 years
Im Jahr 2024 liegt unter dem Median der Branche das verschuldungsgrad von SELARL PHARMACIE DE ROISEL (42.37). Dieses Verhältnis misst das Gewicht der Schulden im Verhältnis zum Eigenkapital. Diese kontrollierte Position spiegelt umsichtiges Management wider.
Finanzielle Autonomie
67.69%2024
2017
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Gut
Im Jahr 2024 liegt über dem Median der Branche das finanzielle autonomie von SELARL PHARMACIE DE ROISEL (67.7%). Dieses Verhältnis stellt den Anteil des Eigenkapitals an der Gesamtfinanzierung dar. Diese komfortable Position bietet eine nennenswerte Sicherheitsmarge.
Liquidity ratios
Die Liquiditätsquote beträgt 1070.29. Das Unternehmen verfügt über 2€ liquide Mittel für jeden 1€ kurzfristiger Schulden.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
1070.294
Liquidity indicators evolution SELARL PHARMACIE DE ROISEL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2023
2024
Liquidity ratio
449.624
706.846
1070.294
Interest coverage
None
None
None
Sector positioning
Liquiditätsquote
1070.292024
2017
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Ausgezeichnet
Im Jahr 2024 liegt in den oberen 25% der Branche das liquiditätsquote von SELARL PHARMACIE DE ROISEL (1070.29). Dieses Verhältnis misst die Fähigkeit, kurzfristige Schulden mit Umlaufvermögen zu decken. Ein Verhältnis über 1 gewährleistet komfortable Deckung kurzfristiger Fälligkeiten.
Positioning of SELARL PHARMACIE DE ROISEL in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE DE ROISEL is estimated at
4 165 744 €
(range 2 900 958€ - 6 232 192€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2900k€4165k€6232k€
4 165 744 €Range: 2 900 958€ - 6 232 192€
NAF 5 année 2024
Valuation method used
Net Income Multiple
298 390 €
×
14.0x
=4 165 745 €
Range: 2 900 959€ - 6 232 193€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE DE ROISEL with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE DE ROISEL
What is the revenue of SELARL PHARMACIE DE ROISEL ?
The revenue of SELARL PHARMACIE DE ROISEL is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE DE ROISEL profitable?
Yes, SELARL PHARMACIE DE ROISEL generated a net profit of 298 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE DE ROISEL ?
The headquarters of SELARL PHARMACIE DE ROISEL is located in ROISEL ([ND]).
Where to find the tax return of SELARL PHARMACIE DE ROISEL ?
The tax return of SELARL PHARMACIE DE ROISEL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE DE ROISEL operate?
SELARL PHARMACIE DE ROISEL operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart